Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008, 49: 652-657. 10.1016/j.jhep.2008.07.014.
Article
PubMed
Google Scholar
Raimondo G, Pollicino T, Cacciola I, Squadrito G: Occult hepatitis B virus infection. J Hepatol. 2007, 46: 160-170. 10.1016/j.jhep.2006.10.007.
Article
PubMed
Google Scholar
Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F, for the Grupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA): Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med. 2004, 5: 171-173. 10.1111/j.1468-1293.2004.00206.x.
Article
CAS
PubMed
Google Scholar
Pérez-Rodríguez MT, Sopeña P, Crespo M, Rivera A, Gonzáles del Blanco T, Ocampo A, Martínez-Vázquez C: Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients. World J Gastroenterol. 2009, 15: 1237-1241. 10.3748/wjg.15.1237.
Article
PubMed
PubMed Central
Google Scholar
Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A, for the HepaICONA and the ICONA Study Groups: Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus infection, virological and immunological features. Infection. 2009, 37: 445-449. 10.1007/s15010-008-8194-9.
Article
CAS
PubMed
Google Scholar
Lo Re V, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Russell Localio A, Kostman JR, Strom BL: Prevalence, risk factors, and outcomes of occult hepatitis B virus infection among HIV-infected patients. J AIDS. 2007, 44: 315-320.
Google Scholar
Jardim RN, Gonzales NS, Pereira JS, Fais VC, Gonzales Junior FL: Occult hepatitis B virus infection in immunocompromised patients. Braz J Infect Dis. 2008, 12: 300-305.
Article
PubMed
Google Scholar
Kusumoto S, Tanaka Y, Mizokami M, Ueda R: Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J STD AIDS. 2009, 20: 336-338. 10.1258/ijsa.2008.008377.
Article
Google Scholar
Bellini C, Keiser O, Chave JP, Evison J, Fehr J, Kaiser L, Weber R, Vernazza P, Bernasconi E, Telenti A, Cavassini M, Swiss HIV Cohort Study: Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Med. 2009, 10: 12-18. 10.1111/j.1468-1293.2008.00646.x.
Article
CAS
PubMed
Google Scholar
Chamorro AJ, Casado JL, Bellido D, Moreno S: Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis. 2005, 24: 492-494. 10.1007/s10096-005-1355-1.
Article
CAS
PubMed
Google Scholar
Clark SJ, Creighton S, Horner M, Smith HM, Portmann B, Taylor C, Cramp ME: Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression. Int J Int J STD AIDS. 2006, 17: 67-69. 10.1258/095646206775220612.
Article
CAS
Google Scholar
Bagaglio S, Porrino L, Lazzarin A, Morsica G: Molecular characterization of occult and overt hepatitis B (HBV) infection in an HIV-infected person with reactivation of HBV after antiretroviral treatment interruption. Infection. 2010, 38: 417-421. 10.1007/s15010-010-0032-1.
Article
CAS
PubMed
Google Scholar
Soriano V, Vispo E, Bottecchia M, Sheldon J, Tuma P, Garcia-Samaniego J, Barreiro P: Management of hepatitis B virus co-infection on and off antiretroviral therapy. Curr HIV/AIDS Rep. 2008, 5: 86-93. 10.1007/s11904-008-0014-4.
Article
PubMed
Google Scholar
Martín-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, González-Lahoz J, Soriano V: Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS. 2011, 25: 73-79. 10.1097/QAD.0b013e328340fde2.
Article
PubMed
Google Scholar
Bhattacharya S, Ijaz S, Ratnaraja N, Smith S, Osmana H, Boxall E: Hepatitis B virus reactivation in a large haemodialysis unit: Virological and infection control issues. J Clin Virol. 2009, 46: 101-103. 10.1016/j.jcv.2009.05.037.
Article
PubMed
Google Scholar
Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM: Reactivation of HBV replication in HIV-HBV infected patients. Am J Med. 2003, 114: 768-769.
Article
PubMed
Google Scholar
Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K, Omura M, Hikiji K, Kato M: Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology. 2003, 37: 1172-1179. 10.1053/jhep.2003.50171.
Article
CAS
PubMed
Google Scholar
Blackberg J, Kidd-Ljunggren K: Occult hepatitis B virus after acute selflimited infection persisting for 30 years without sequence variation. J Hepatol. 2000, 33: 992-997. 10.1016/S0168-8278(00)80134-8.
Article
CAS
PubMed
Google Scholar
Locarnini S: Hepatitis B viral resistance: mechanisms and diagnosis. J Hepatol. 2003, 39 (suppl): 124-132.
Article
Google Scholar
Coleman PF: Detecting hepatitis B surface antigen mutants. EID. 2006, 12: 198-203.
CAS
Google Scholar
Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, Manns MP, Trautwein C: Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterol. 2002, 122: 264-273. 10.1053/gast.2002.31015.
Article
CAS
Google Scholar
Pondé RA: The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile". Eur J Microbiol Infect Dis. 2011,
Google Scholar
Cohen Stuart JV, Velema M, Schuurman R, Boucher CA, Hoepelman AI: Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol. 2009, 8: 441-445.
Article
Google Scholar
Tsui JI, Frennch AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC: Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis. 2007, 45: 736-740. 10.1086/520989.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G: The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterol. 2008, 134: 1470-1481. 10.1053/j.gastro.2008.02.017.
Article
CAS
Google Scholar
Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF: Nomenclature for antiviral-resistant hepatitis B virus mutations inthe polymerase region. Hepatology. 2001, 33: 751-757. 10.1053/jhep.2001.22166.
Article
CAS
PubMed
Google Scholar